Multivessel Disease (MVD): 60 Second Insights

Published: 08 March 2018

  • Views:

    Views Icon 1914
  • Likes:

    Heart Icon 7
  • episode_image
    Now Playing
    Part 6 | Session 3 of 4
    Paul Knaapen
    Paul Knaapen
    Up Next
  • episode_image
    49s
    Part 6 | Session 4 Colin Berry
    Colin Berry
Average (ratings)
No ratings
Your rating

Overview

A short series of 60-second insight videos on Multivessel Disease (MVD).

More from this programme

Part 1

How do manage patients with multi-vessel disease during PPCI?

Part 2

Do you think we should be doing multi-vessel revascularisation instead of CABG? If so, in which cases?

Part 3

Do you prefer Clopidogrel, Ticagrelor or Prasugrel?

Part 4

Do you have any concerns giving adenosine during PPCI or would your prefer and adenosine-free technique?

Part 5

Do you believe registry (i.e. culprit only) or RCT data (treat all vessels)?

Part 6

Do you believe coronary physiology has a role in non-culprit PPCI decision-making?

Part 7

Are you using G2B3A inhibitors like ReoPro?

Part 8

Are you using Bivalirudin or Heparin?

Part 9

What trials best support the use of MVD PCI?

Part 10

Should we balloon acutely and then returning to stent the following morning?

Part 11

Should PPCI be performed at large surgical centres only?

Faculty Biographies

Paul Knaapen

Paul Knaapen

Interventional Cardiologist and Professor

Personal History

Dr Paul Knaapen is an Interventional Cardiologist, the Director of Cardiac PET/CT and a Professor of Interventional Cardiology at Amsterdam UMC, Netherlands. 4

 

Academic History

Dr Knaapen received his M.D. from the VU University School of Medicine. He then completed his internship, residency and interventional cardiology fellowship at the VU University Medical Center.5

 

Career Overview

Dr Knaapen is Professor of Cardiac Intervention and Imaging, Division of Cardiology at the VU University Medical Center, where his major research interest is the clinical value of non‐invasive cardiac imaging, with a particular focus on hybrid PET/CT and chronic total occlusions (CTOs).5

As a clinical researcher, he has co-authored 223 peer-reviewed articles and participated in 7…

View full profile